GeneDx Holdings Corp. (WGS) Deferred Income Tax Expense (Benefit)

GeneDx Holdings Corp. Deferred Income Tax Expense (Benefit)

GeneDx Holdings Corp. (WGS) reported Deferred Income Tax Expense (Benefit) of -$981.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-23

• GeneDx Holdings Corp. deferred income tax expense (benefit) for the quarter ending 2022-06-30 was -$48.60M.
• GeneDx Holdings Corp. deferred income tax expense (benefit) for fiscal 2025 was -$981.00K.
• GeneDx Holdings Corp. deferred income tax expense (benefit) for fiscal 2024 was -$584.00K.
• GeneDx Holdings Corp. deferred income tax expense (benefit) for fiscal 2023 was -$1.09M.
• GeneDx Holdings Corp. deferred income tax expense (benefit) for fiscal 2022 was -$49.12M.